Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo

Journal of Virology

Volumn 74, Issue 13, 2000, Pages 5902-5910

  Zheng, Zhi Ming ^a   Quintero, Jesse ^a   Reid, Eric S ^a   Gocke, Christian ^a   Baker, Carl C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; EXON; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MUTATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRUS CAPSID;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BINDING SITES; BOVINE PAPILLOMAVIRUS 1; CATTLE; CELL LINE, TRANSFORMED; EXONS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; RNA PRECURSORS; RNA, VIRAL;

EID: 0034094219     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.13.5902-5910.2000     Document Type: Article

References (55)

1. Bai, Y. D., D. Lee, T. D. Yu, and L. A. Chasin. 1999. Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res. 27:1126-1134.
2. Barksdale, S. K., and C. C. Baker. 1995. Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J. Virol. 69:6553-6556.
3. Buvoli, M., S. A. Mayer, and J. G. Patton. 1997. Functional crosstalk between exon enhancers, polypyrimidine tracts and branchpoint sequences. EMBO J. 16:7174-7183.
4. Caceres, J. F., S. Stamm, D. M. Helfman, and A. R. Krainer. 1994. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265:1706-1709.
5. Caputi, M., A. Mayeda, A. R. Krainer, and A. M. Zahler. 1999. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 18:4060-4067.
6. Chen, C. D., R. Kobayashi, and D. M. Helfman. 1999. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat β-tropomyosin gene. Genes Dev. 13:593-606.
7. Chew, S. L., H. X. Liu, A. Mayeda, and A. R. Krainer. 1999. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 96:10655-10660.
8. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995.
9. Del Gatto-Konczak, F., M. Olive, M. C. Gesnel, and R. Breathnach. 1999. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19:251-260.
10. Fang, G., B. Weiser, A. Visosky, T. Moran, and H. Burger. 1999. PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA. Nat. Med. 5:239-242.
11. Fu, X. Y., H. Ge, and J. L. Manley. 1988. The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3′ splice site in alternative splicing. EMBO J. 7:809-817.
12. Ge, H., and J. L. Manley. 1990. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62:25-34.
13. Ghigna, C., M. Moroni, C. Porta, S. Riva, and G. Biamonti. 1998. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res. 58:5818-5824.
14. Graveley, B. R., K. J. Hertel, and T. Maniatis. 1998. A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J. 17:6747-6756.
15. Green, M. R. 1986. Pre-mRNA splicing. Annu. Rev. Genet. 20:671-708.
16. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
17. Kanaar, R., S. E. Roche, E. L. Beall, M. R. Green, and D. C. Rio. 1993. The conserved pre-mRNA splicing factor U2AF from Drosophila: requirement for viability. Science 262:569-573.
18. Kanopka, A., O. Mühlemann, S. Petersen-Mahrt, C. Estmer, C. Öhrmalm, and G. Akusjärvi. 1998. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393:185-187.
19. Krainer, A. R., G. C. Conway, and D. Kozak. 1990. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell 62:35-42.
20. Mayeda, A., G. R. Screaton, S. D. Chandler, X. D. Fu, and A. R. Krainer. 1999. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol. Cell. Biol. 19:1853-1863.
21. Moore, M. J., C. C. Query, and P. A. Sharp. 1993. Splicing of precursors to messenger RNAs by the spliceosome, p. 303-357. In R. F. Gestland and J. F. Atkins (ed.), The RNA world. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
22. Mullen, M. P., C. W. Smith, J. G. Patton, and B. Nadal-Ginard. 1991. Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice. Genes Dev. 5:642-655.
23. Muro, A. F., M. Caputi, R. Pariyarath, F. Pagani, E. Buratti, and F. E. Baralle. 1999. Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol. Cell. Biol. 19:2657-2671.
24. Norton, P. A. 1994. Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res. 22: 3854-3860.
25. Padgett, R. A., P. J. Grabowski, M. M. Konarska, S. Seiler, and P. A. Sharp. 1986. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55:1119-1150.
26. Parker, R., P. G. Siliciano, and C. Guthrie. 1987. Recognition of the TAC-TAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell 49:229-239.
27. Potashkin, J., K. Naik, and K. Wentz-Hunter. 1993. U2AF homolog required for splicing in vivo. Science 262:573-575.
28. Prasad, J., K. Colwill, T. Pawson, and J. L. Manley. 1999. The protein kinase Clk/Sty directly modulates SR protein activity: both hyper-and hypophosphorylation inhibit splicing. Mol. Cell. Biol. 19:6991-7000.
29. Ramchatesingh, J., A. M. Zahler, K. M. Neugebauer, M. B. Roth, and T. A. Cooper. 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15:4898-4907.
30. Reed, R. 1989. The organization of 3′ splice-site sequences in mammalian introns. Genes Dev. 3:2113-2123.
31. Roscigno, R. F., M. Weiner, and M. A. Garcia-Blanco. 1993. A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268:11222-11229.
32. Sanford, J. R., and J. P. Bruzik. 1999. Developmental regulation of SR protein phosphorylation and activity. Genes Dev. 13:1513-1518.
33. Schaal, T. D., and T. Maniatis. 1999. Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol. Cell. Biol. 19:261-273.
34. Si, Z. H., B. A. Amendt, and C. M. Stoltzfus. 1997. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res. 25:861-867.
35. Singh, R., J. Valcarcel, and M. R. Green. 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268:1173-1176.
36. Smith, C. W., E. B. Porro, J. G. Patton, and B. Nadal-Ginard. 1989. Scanning from an independently specified branch point defines the 3′ splice site of mammalian introns. Nature 342:243-247.
37. Staffa, A., and A. Cochrane. 1994. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site. J. Virol. 68:3071-3079.
38. Staffa, A., and A. Cochrane. 1995. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15:4597-4605.
39. Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14:7670-7682.
40. Stark, J. M., D. P. Bazett-Joness, M. Herfort, and M. B. Roth. 1998. SR proteins are sufficient for exon bridging across an intron. Proc. Natl. Acad. Sci. USA 95:2163-2168.
41. Stickeler, E., F. Kittrell, D. Medina, and S. M. Berget. 1999. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18:3574-3582.
42. Tanaka, K., A. Watakabe, and Y. Shimura. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14:1347-1354.
43. Umen, J. G., and C. Guthrie. 1995. The second catalytic step of pre-mRNA splicing. RNA 1:869-885.
44. Wang, J., and J. L. Manley. 1995. Overexpression of the SR proteins ASF/ SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335-346.
45. Wu, J., and J. L. Manley. 1989. Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev. 3:1553-1561.
46. Zamore, P. D., J. G. Patton, and M. H. Green. 1992. Cloning and domain structure of the mammalian splicing factor U2AF. Nature 355:609-614.
47. Zhang, L., and C. M. Stoltzfus. 1995. A suboptimal src 3′ splice site is necessary for efficient replication of Rous sarcoma virus. Virology 206:1099-1107.
48. Zhang, M. Q. 1998. Statistical features of human exons and their flanking regions. Hum. Mol. Genet. 7:919-932.
49. Zheng, Z. M., and C. C. Baker. 2000. Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs. J. Virol. Methods 85:203-214.
50. Zheng, Z. M., P. J. He, and C. C. Baker. 1996. Selection of the bovine papillomavirus type 1 nucleotide 3225 3′ splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J. Virol. 70:4691-4699.
51. Zheng, Z. M., P. J. He, and C. C. Baker. 1997. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers. J. Virol. 71:9096-9107.
52. Zheng, Z. M., P. J. He, and C. C. Baker. 1999. Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3′ splice site. J. Virol. 73:29-36.
53. Zheng, Z. M., M. Huynen, and C. C. Baker. 1998. A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceo-some assembly. Proc. Natl. Acad. Sci. USA 95:14088-14093.
54. Zhuang, Y., and A. M. Weiner. 1989. A compensatory base change in human U2 snRNA can suppress a branch site mutation. Genes Dev. 3:1545-1552.
55. 35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. Genes Dev. 10:1356-1368.